A controlled trial of antihuman lymphocyte globulin (Behring) in cadaveric renal transplantation: improvement in graft and patient survival at one year using a high-dose regimen.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples